193 related articles for article (PubMed ID: 15533226)
21. Chronic allograft nephropathy and nephrotic range proteinuria.
Ramanathan V; Suki WN; Rosen D; Truong LD
Clin Transplant; 2005 Jun; 19(3):413-7. PubMed ID: 15877807
[TBL] [Abstract][Full Text] [Related]
22. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and immunohistochemical findings of subclinical kidney allograft rejection and its association with graft outcome.
Veronese FV; Noronha IL; Manfro RC; Edelweiss MI; Goldberg J; Gonçalves LF
Clin Transplant; 2004 Aug; 18(4):357-64. PubMed ID: 15233810
[TBL] [Abstract][Full Text] [Related]
24. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
Waid T;
Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
[TBL] [Abstract][Full Text] [Related]
25. Proteinuria after kidney transplantation: its relation to hepatitis C virus and graft outcome.
Sabry A; Hassan R; Mahmoud I; Hamed M; Sobh M
Iran J Kidney Dis; 2007 Oct; 1(2):88-97. PubMed ID: 19363283
[TBL] [Abstract][Full Text] [Related]
26. Recurrent mesangial IgA nephritis following renal transplantation.
Odum J; Peh CA; Clarkson AR; Bannister KM; Seymour AE; Gillis D; Thomas AC; Mathew TH; Woodroffe AJ
Nephrol Dial Transplant; 1994; 9(3):309-12. PubMed ID: 8052439
[TBL] [Abstract][Full Text] [Related]
27. Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy.
Falger JC; Mueller T; Arbeiter K; Boehm M; Regele H; Balzar E; Aufricht C
Pediatr Transplant; 2006 Jun; 10(4):474-8. PubMed ID: 16712606
[TBL] [Abstract][Full Text] [Related]
28. [A case of recurrent IgA nephropathy following renal transplantation under tacrolimus (FK506)].
Takao T; Hatori M; Ichimaru N; Honda M; Nonomura N; Matsumiya K; Kokado Y; Takahara S; Okuyama A; Miyamoto M; Yokoyama K; Imai E; Kyo M
Hinyokika Kiyo; 1997 Sep; 43(9):661-4. PubMed ID: 9365847
[TBL] [Abstract][Full Text] [Related]
29. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
30. IgA nephropathy in kidney allograft recipients-therapeutic perspective.
Pazik J; Baczkowska T; Lewandowski Z; Lewandowska D; Ostrowska J; Perkowska Ptasińska A; Mróz A; Miszewska-Szyszkowska D; Rowinski W; Durlik M
Transplant Proc; 2006; 38(1):112-4. PubMed ID: 16504678
[TBL] [Abstract][Full Text] [Related]
31. New aspects of posttransplant nephrotic syndrome: clinicopathologic correlations with outcomes.
Yakupoğlu U; Baranowska-Daca E; Suki WN; Truong LD
Transplant Proc; 2004; 36(1):139-43. PubMed ID: 15013326
[TBL] [Abstract][Full Text] [Related]
32. [Severe proteinuria in IgA nephropathy. Clinicopathological study of 8 cases with 100 serial sections].
Shouno Y; Shimokama T; Sakemi T; Harada A; Watanabe T
Nihon Jinzo Gakkai Shi; 1993 Sep; 35(9):1043-50. PubMed ID: 8230814
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of patients with rejection post-polyomavirus nephropathy.
Trofe J; Roy-Chaudhury P; Gordon J; Wadih G; Maru D; Cardi MA; Succop P; Alloway RR; Khalili K; Woodle ES
Transplant Proc; 2005 Mar; 37(2):942-4. PubMed ID: 15848582
[TBL] [Abstract][Full Text] [Related]
34. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
35. Segmental glomerulosclerosis in IgA nephropathy after renal transplantation: relationship with proteinuria and therapeutic response to enalapril.
Jeong HJ; Kim YS; Kwon KW; Kim MS; Kim S; Choi KH; Lee HY; Han DS; Park K
Clin Transplant; 2003 Apr; 17(2):108-13. PubMed ID: 12709075
[TBL] [Abstract][Full Text] [Related]
36. Factors predicting progression of IgA nephropathies.
Coppo R; D'Amico G
J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
[TBL] [Abstract][Full Text] [Related]
37. Recurrence of IgA nephropathy and Henoch-Schönlein purpura after kidney transplantation: risk factors and graft survival.
Soler MJ; Mir M; Rodriguez E; Orfila A; Munne A; Vázquez S; Lloveras J; Puig JM
Transplant Proc; 2005 Nov; 37(9):3705-9. PubMed ID: 16386512
[TBL] [Abstract][Full Text] [Related]
38. Adverse impact of pretransplant polyoma virus infection on renal allograft function.
Hayat A; Mukhopadhyay R; Radhika S; Sachdeva MS; Nada R; Joshi K; Sakhuja V; Jha V
Nephrology (Carlton); 2008 Apr; 13(2):157-63. PubMed ID: 18275505
[TBL] [Abstract][Full Text] [Related]
39. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy?
Courtney AE; McNamee PT; Nelson WE; Maxwell AP
Nephrol Dial Transplant; 2006 Dec; 21(12):3550-4. PubMed ID: 16968729
[TBL] [Abstract][Full Text] [Related]
40. Proteinuria after conversion to sirolimus in renal transplant recipients.
Sahin GM; Sahin S; Kantarci G; Ergin H
Transplant Proc; 2006 Dec; 38(10):3473-5. PubMed ID: 17175308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
